Pluriomics' Grant

Pluriomics raised a round of funding on March 01, 2016. Investors include Horizon 2020.

Pluriomics is a Belgian/Dutch biotechnology company whose mission is to deliver cardiac drug discovery and safety solutions based on its best-in-class human iPSC-derived cardiomyocyte technology. Spec…

Articles about Pluriomics' Grant: